03/27/2017 | 09:50pm CEST
Eastside Distilling, Inc. (the “Company”) is currently offering up to 1,200,000 units (the “Units”) at $1.30 per Unit, each Unit consisting one share of common stock and one three year common stock purchase warrant exercisable at $2.50 per share (subject to adjustment), for total gross proceeds of up to $1,560,000 (the “Unit Offering”). The Unit Offering described above is being offered to exemptions from the registration requirements of the Securities Act of 1933, as amended, and will be made to a limited number of accredited investors to a Confidential Private Offering Memorandum.
This Current Report on Form 8-K is not an offer to sell or the solicitation of an offer to buy the Units. The disclosure provided in this Current Report on Form 8-K is being made to ensure compliance with certain prior agreements between the Company and MR Group I, LLC whereby the Company has granted MR Group I a right of first refusal in connection with certain securities offerings, while also agreeing that it will not disclose to MR Group I any material non-public information, such as the fact that the Company has undertaken to make an offering of securities.
Recent EAST News
- Eastside Distilling, Inc. to Report 2024 First Quarter Results on Monday, May 13, 2024 • PR Newswire (US) • 05/02/2024 06:13:00 PM
- Eastside Distilling Reports Fourth Quarter 2023 Financial Results • PR Newswire (US) • 04/01/2024 08:30:00 PM
- Eastside Distilling, Inc. to Report 2023 Fiscal Year Results on Monday, April 1, 2024 • PR Newswire (US) • 03/27/2024 02:36:00 PM
- Eastside Distilling to Attend the 36th Annual Roth Conference March 17-19, 2024 and schedules 4th Quarter Earnings Call • PR Newswire (US) • 03/11/2024 06:56:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 03:45:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/31/2024 05:30:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 03:54:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 05:32:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2023 04:50:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/12/2023 04:57:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 03:45:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 04:52:12 PM
- Eastside Distilling Reports Third Quarter 2023 Financial Results • PR Newswire (US) • 11/14/2023 09:10:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/07/2023 05:15:34 AM
- Eastside Distilling, Inc. to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023 • PR Newswire (US) • 11/06/2023 05:18:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 07:28:47 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/25/2023 07:34:48 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/25/2023 07:20:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 10:51:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 10:51:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 10:51:05 PM
- Eastside Distilling Announces Completion of Debt-for-Equity Exchange • PR Newswire (US) • 10/02/2023 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 08:17:20 PM
- Eastside Distilling Reports Second Quarter 2023 Financial Results • PR Newswire (US) • 08/14/2023 08:40:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM